A Hoosier Oncology Group Phase II Study of Biweekly Cisplatin (C) and Paclitaxel (P) in the Treatment of Metastatic Breast Cancer: A Hoosier Oncology Group (HOG) and Walther Cancer Institute Trial BRE94-1

Abstracts/Posters/Presentations:

• McCaskill-Stevens W, Ansari R, Fisher W, Pennington K, Dobbs C, Gonin R, Schafer S, Loesch D, Sledge G. A Hoosier Oncology Group Phase II Study of Biweekly Cisplatin (C) and Paclitaxel (P) in the Treatment of Metastatic Breast Cancer: A Hoosier Oncology Group (HOG) and Walther Cancer Institute Trial BRE94-1. Accepted to the ASCO Annual Meeting May 18-21, 1996, Philadelphia, PA.